Skip to main content

Table 4 Laboratory findings in the study subjects with chronic liver disease, by aetiology

From: Unexplained chronic liver disease in Ethiopia: a cross-sectional study

Laboratory variable

All patients (n = 150)

Aetiology known (n = 67)

Aetiology unknown (n = 83)

ALT (U/L)

34 (22–55)

41 (24–58)

30 (21–51)*

  > URR

60 (40.0)

34 (50.7)

26 (31.3)*

AST (U/L)

44 (28–81)

52 (31–83)

41 (28–78)

  > URR

84 (56.0)

41 (61.2)

43 (51.8)

ALP (U/L)

317 (207–416)

315 (250–423)

320 (200–385)

  > URR

80 (53.3)

37 (55.2)

43 (51.8)

GGT (U/L)

29 (19–48)

29 (21–47)

29 (18–52)

  > URR

30 (20.0)

14 (20.9)

16 (19.3)

Total bilirubin (μmol/L)

19 (10–38)

21 (12–51)

17 (10–31)

  > URR

36 (24.0)

20 (29.9)

16 (19.3)

Albumin (g/L)

37 (28–50)

36 (30–50)

37 (27–50)

  < LRR

63 (42.0)

27 (40.3)

36 (43.4)

Creatinine (μmol/L)

80 (62–97)

80 (62–97)

71 (62–88)

  > URR

23 (15.3)

11 (16.4)

12 (14.5)

  < LRR

19 (12.7)

8 (11.9)

11 (13.3)

Platelet count (109/L)

125 (76–206)

123 (71–186)

147 (76–223)

  < LRR

75 (50.0)

36 (53.7)

39 (47.0)

IgG (g/L)

23.9 (17.1–32.5)

27.0 (16.7–34.2)

21.6 (17.2–30.6)

  > URR

55 (36.7)

31 (46.3)

24 (28.9)

HIV infectiona

4 (2.7)

1 (1.5)

3 (3.6)

Kato-Katz smear positive

23 (16.5)b

13 (21.3)c

10 (12.8)d

APRI score > 0.7e

92 (61.7)f

46 (69.7)f

46 (55.4)

FIB-4 score > 3.25g

43 (28.9)f

20 (30.3)f

23 (27.7)

APRI score > 0.7 OR

FIB-4 score > 3.25

94 (63.1)f

46 (69.7)f

48 (57.8)

  1. Data are presented as number (%) or as median (interquartile range)
  2. Laboratory reference ranges: ALT (8–40 U/L); AST (14–40 U/L); ALP (60–306 U/L); GGT (7–61 U/L); Bilirubin (3–38 μmol/L); Albumin (35–52 g/L); Creatinine (47–109 μmol/L); Platelet count (126–438 × 109/L); IgG (0.8–27.8 g/L) [21]
  3. aOne patient with chronic HCV was co-infected with HIV.
  4. bStool sample missing in 11 patients.
  5. cStool sample missing in six patients.
  6. dStool sample missing in five patients.
  7. eAPRI: (AST (U/L)/URR of AST (U/L))/platelet count (109/L) × 100
  8. fOne observation missing.
  9. gFIB-4: age (years) x AST (U/L)/(platelet count (109/L) x √ALT (U/L))
  10. *p < 0.05; significance of the difference between the aetiology known/unknown group
  11. Abbreviations: ALP alkaline phosphatase, ALT alanine aminotransferase, APRI aspartate aminotransferase to platelets ratio index, AST aspartate aminotransferase, GGT gamma-glutamyltransferase, HCV hepatitis C virus, HIV human immunodeficiency virus, IgG immunoglobulin G, LRR lower reference range, URR upper reference range